Search Results

CORRECTION_Lanza.

Subjects: *LYMPHOMAS; *IMMUNOLOGICAL adjuvants; *PATIENTS

• Source: Transfusion. Jun2014, Vol. 54 Issue 6, p1688-1691. 4p.

Record details

Immunomodulatory effect of cryopreserved platelets: altered BDCA3+ dendritic cell maturation and activation in vitro.

• Authors : Ki, Katrina K.^1,2 ; Johnson, Lacey³; Faddy, Helen M.^1,2

Subjects: *IMMUNOLOGICAL adjuvants; *CRYOPRESERVATION of organs, tissues, etc.; *BLOOD platelets

• Source: Transfusion. Dec2017, Vol. 57 Issue 12, p2878-2887. 10p.

Record details

Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.

• Authors : Spoerl, Silvia¹; Peter, Robert¹; Wäscher, Dagmar¹

Subjects: *IMMUNOLOGICAL adjuvants; *STEM cell transplantation; *AUTOTRANSPLANTATION

• Source: Transfusion. Jan2017, Vol. 57 Issue 1, p115-121. 7p. 1 Chart, 2 Graphs.

Record details

A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs.

• Authors : Chabannon, Christian^1,2,3; Bijou, Fontanet^4,5; Miclea, Jean‐Michel⁶

Subjects: *IMMUNOLOGICAL adjuvants; *HEMATOPOIETIC stem cells; *LYMPHOID tissue

• Source: Transfusion. Sep2015, Vol. 55 Issue 9, p2149-2157. 9p. 3 Charts.

Record details

Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factor.

• Authors : Bilgin, Yavuz M.¹; Visser, Otto²; Beckers, Erik A.M.³

Subjects: *IMMUNOLOGICAL adjuvants; *GRANULOCYTE colony stimulating factor receptor; *JUST-in-time systems

• Source: Transfusion. May2015, Vol. 55 Issue 5, p1021-1027. 7p.

Record details

Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization.

• Authors : Yuan, Shan¹; Nademanee, Auayporn²; Kaniewski, Mark¹

Subjects: *HODGKIN'S disease treatment; *IMMUNOLOGICAL adjuvants; *STEM cells

• Source: Transfusion. Aug2014, Vol. 54 Issue 8, p2015-2021. 7p.

Record details

Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.

• Authors : Wallenhorst, Christopher; Patel, Ami; Shebl, Amgad

Subjects: HEMOLYTIC anemia; IMMUNOAFFINITY chromatography; MEDICAL records

• Source: Transfusion; Jul2020, Vol. 60 Issue 7, p1381-1390, 10p, 1 Diagram, 5 Charts

Record details

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports.

• Authors : Shebl, Amgad; Gabriel, Susie; Van Dinther, Kristy

Subjects: ABO blood group system; IMMUNOGLOBULINS; HEMOLYSIS & hemolysins

• Source: Transfusion; Jun2020, Vol. 60 Issue 6, p1278-1286, 9p, 4 Charts, 4 Graphs

Record details

Isohemagglutinin titering performed on an automated solid-phase and hemagglutinin-based analyzer is comparable to results obtained by manual gel testing.

• Authors : Lally, Kimberly; Kruse, Robert L.; Smetana, Heather

Subjects: IMMUNOGLOBULIN M; COLLOIDS; STEM cell transplantation

• Source: Transfusion; Mar2020, Vol. 60 Issue 3, p628-636, 9p, 1 Diagram, 2 Charts, 3 Graphs

Record details

Isoagglutinin-reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin-associated hemolysis.

• Authors : Cen, Selena Y.; Branch, Donald R.

Subjects: IDIOPATHIC thrombocytopenic purpura; RHEUMATOID arthritis; HEMOLYSIS & hemolysins

• Source: Transfusion; Feb2020, Vol. 60 Issue 2, p250-255, 6p, 2 Graphs

Record details